- Rating
- 1
- Confidence
- 3
- Informativeness
- 1
- Presentation
- 1
- Soundness
- 2
Read review
Paper summary
Authors present PhyGRec, a new method for deconvolving gene expression data into individual cells by incorporating spatial data and refinements over multiple iteration. Contributions include a new architecture that includes iterative refinement through backprojection and the authors demonstrated greater performance with respect to SOTA methods that use graph attention and similar techniques
Critical strengths
Strengths include a well-calibrated architecture design
- The overall problem is highly impactful, spatial data is very expensive to generate and still exists only at a limited scale, which is relevant for several disease classes such as cancer micro-environment
- A more advanced architecture for deconvolving expression data
- Performance shows clear improvements in deconvolutions
Critical weaknesses
Overall, the paper is confusing and hard to follow for a human. The introduction does not properly introduce the problem
- It is not clear for the average reader what stereo-seq is, not what a stereo cell is
- Problem and overall universe are not clearly defined
- For example, “measured chip’s” not clear what chip is referring to? Chip-seq maybe?
- Past contributions and novelty are not properly flowing in the introduction
-
Ablations in table 3 benchmark show modest contributions of the physics addition
Questions for authors
- The contribution here is clearly on the domain application. Would it be possible to expand to other cell types?
- Would it be possible to test on histological section data from spatial RNA-seq/proteomic data?
Thank you for your careful review and constructive suggestions. We have revised the Introduction to clarify the task and contribution, explained the component ablations, and expanded the discussion of future validation. We address the weaknesses and questions below.
W1. The Introduction does not clearly establish Stereo-seq, Stereo-cell, chip, or the recovery problem.
A1. The submitted Introduction cites Chen et al. (2022) and Wei et al. (2022) for Stereo-seq's DNA-nanoball arrays, and Liao et al. (2025) for Stereo-cell profiling of dissociated cells.
We have revised the opening of Section 1 to define a capture chip as the physical array, a footprint as a segmented cell region, and Reference as the receiver's measured profile before controlled mixing. We also clarify directional donor contributions and the model inputs: mixed expression and coordinate-derived candidates, with source profiles and transfer coefficients hidden.
W2. The prior contributions and novelty do not flow clearly in the Introduction.
A2. SoupX and DecontX address ambient RNA; SpotClean addresses spot swapping. Our task recovers cell-specific profiles from directional footprint mixing with hidden overlap edges and coefficients. PhyGRec couples a learned mixing surrogate with residual backprojection, adaptive increment modulation and graph-context refinement for this recovery task. We have revised Section 1 to make this task-to-method connection explicit and added matched graph comparisons and recent inverse-method adaptations in Section 4.6.
W3. The ablations show a modest contribution from the physics component.
A3. RB uses the circle-overlap surrogate to backproject measurement residuals (Sections 3.3–3.4). Its ablation retains the circle operator and candidate graph and sets the backprojection increment to zero. Removing RB increases mean Log-MAE from 0.00369 to 0.00657. Table 3 reports three-seed mean ± sample SD:
Parameter counts include all registered trainable parameters in each evaluated architecture. AIM modulates the RB increment through learned gain and momentum, and GCC adds a graph-context correction. Removing AIM disables both gain and momentum; AIM and GCC removals also reduce the parameter count. All nine paired-seed Log-MAE comparisons favor the full model. We have clarified the RB removal and the AIM/GCC ablations in Section 4.5. Table 21 separately evaluates the circle coefficients against the generator.
Q1. Can the evaluation extend to other cell types?
A1. The recovery benchmark covers the cell populations represented in dissociated PBMCs. We have revised Section 5 to clarify this scope and discuss validation on other cell types with independent references as future work.
Q2. Can the method be tested on histological sections or proteomic data?
A2. We have expanded Section 5 to discuss histological sections and spatial proteomics as future research directions, using assay-specific mixing models and independent references for evaluation.